Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | G007-LK |
| Trade Name | |
| Synonyms | |
| Drug Descriptions |
G007-LK inhibits tankyrase, which leads to stabilization of AXIN, thereby resulting in degradation of beta-catenin and decreased growth of APC-deficient tumors (PMID: 23539443, PMID: 32575464). |
| DrugClasses | Tankyrase Inhibitor 11 |
| CAS Registry Number | 1380672-07-0 |
| NCIT ID | NA |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Buparlisib + G007-LK | Buparlisib G007-LK | 1 | 0 |
| G007-LK | G007-LK | 35 | 0 |
| G007-LK + Imatinib | G007-LK Imatinib | 1 | 0 |
| G007-LK + Trametinib | G007-LK Trametinib | 3 | 0 |